Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Implementation of a Transparent Registry Based on FAIR Principles for Duchenne and Becker Muscular Dystrophy (DBMD) Under the Auspices of the Society for Neuropediatrics (GNP) - FAIR-DMD

NCT07402122 is registered in ClinicalTrials.gov with Dr. Andreas Ziegler as lead sponsor.

NCT NCT07402122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07402122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Implementation of a Transparent Registry Based on FAIR Principles for Duchenne and Becker Muscular Dystrophy (DBMD) Under the Auspices of the Society for Neuropediatrics (GNP) - FAIR-DMD
Lead sponsor
Dr. Andreas Ziegler
Phase
Observational
Overall status
Recruiting
Start date
July 13, 2026
Completion date
June 30, 2041
Enrollment
1,500 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

becker muscular dystrophy, duchenne muscular dystrophy (dmd), dystrophinopathy symptomatic female carrier